IP Library › Granted Patent US 12,318,461
Granted Patent B2
US 12,318,461 · App. 17/373,070 · Granted Jun 3, 2025

Salicylic acid gel

Inventors: Chris D. Gerlach (Buford, GA); Michael B. Davies (Dacula, GA)
Assignee: Vantage Specialty Ingredients, Inc.
A61K8/042A61K8/342A61K8/365A61K8/42A61K8/731A61K8/86A61K9/0014A61K9/06A61K31/16A61K31/60A61K47/10A61K47/18A61K47/38A61Q5/006A61Q5/02A61Q19/00A61Q19/007A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,318,461
App. No.
17/373,070
Granted
Jun 3, 2025
Kind
B2
Abstract

A salicylic acid gel contains salicylic acid, a thickener, and a stabilizer compound. The gel may be diluted and/or incorporated into final skin care products.

Claims (15)

1. A composition in the form of a stable gel and containing, based on the total weight of the gel:

a. salicylic acid which is normally soluble in water, but which is present in the gel in soluble form in an amount of at least 30 wt. %;

b. a stabilize liquid nitrogen-containing compound that is an alkylamido amine which functions as a stabilizer (hereafter for convenience “stabilizer”) and is present in an amount of at least 40 wt. %, wherein said stabilizer and the amount thereof function to form said stable gel by solubilizing and dissolving said salicylic acid; and

c. at least one polyethylene glycol thickener in an amount of at least 1 wt. %.

2. The concentrated salicylic acid gel according to claim 1 , wherein the polyethylene glycol thickener is present in an amount of at least 5 wt. %.

3. The concentrated salicylic acid gel according to claim 1 , wherein the polyethylene glycol thickener is present in an amount of at least 20 wt. %.

4. The concentrated salicylic acid gel according to claim 1 , wherein the polyethylene glycol thickener is present in an amount of at least 30 wt. %.

5. The concentrated salicylic acid gel according to claim 1 , wherein the polyethylene glycol thickener is present in an amount of 20 wt. % to 50 wt. %.

6. The concentrated salicylic acid gel according to claim 1 , wherein the polyethylene glycol thickener is present in an amount of up to 50 wt. %.

7. The concentrated salicylic acid gel according to claim 1 consisting of 30 to 60 wt. % salicylic acid, 40 to 70 wt. % stabilizer, and 1 to 20 wt. % polyethylene glycol thickener.

8. The concentrated salicylic acid gel according to claim 1 consisting of 35 to 55 wt. % salicylic acid, 45 to 60 wt. % stabilizer, and 5 to 20 wt. % polyethylene glycol thickener.

9. The concentrated salicylic acid gel according to claim 1 , wherein the stabilizer is cocamidopropyl dimethylamine.

10. The concentrated salicylic acid gel according to claim 1 wherein the thickener is at least one selected from the group consisting of agar, algin pectin, bentonite, chitosan, cellulose, carrageenan, chitin, cassia gum, cetyl glycol, clay, croscarmellose, dextrin, xanthan gum, gelatin, hectorite, silica, hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, microcrystalline cellulose, pectin, polyester-5, polyether-1, polyglycerin-20, polyglycerin-40, sclerotium gum, sodium stearate, starch, beeswax, ceresin, an alcohol, or a polyethylene glycol.

11. The concentrated salicylic acid gel according to claim 1 wherein the polyethylene glycol thickener is selected from the group consisting of PEG-450, PEG-800, PEG-2M, PEG-SM, PEG-7M, PEG-9M, PEG-14M, PEG-20M, PEG-23M, PEG-25M, PEG-45M, PEG-65M, PEG-90M, PEG-115M, PEG-160M, and PEG-180M.

12. The composition according to claim 1 consisting of salicylic acid, cocamidopropl dimethylaminem, and at least one polyethylene glycol thickener is selected from the group consisting of PEG-450, PEG-800, PEG-2M, PEG-SM, PEG-7M, PEG-9M, PEG-14M, PEG-20M, PEG- 23M, PEG-25M, PEG-45M, PEG-65M, PEG-90M, PEG-115M, PEG-160M, and PEG- 180M.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Sep 4, 2025
From: VANTAGE SPECIALTIES, INC.; VANTAGE SPECIALTY CHEMICALS, INC.; VANTAGE SPECIALTY INGREDIENTS, INC.
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 072801/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2023
From: ESSENTIAL INGREDIENTS, INC.
To: VANTAGE SPECIALTY INGREDIENTS, INC.
Reel/Frame 065915/0251 →
Continuity (7)
Continuation 15880764 · Jan 26, 2018
Continuation 14329063 · Jul 11, 2014
Continuation In Part PCTUS2013062561 · Sep 30, 2013
Continuation In Part 13789780 · Mar 8, 2013
Provisional Application 61990144 · May 8, 2014
Provisional Application 61615956 · Mar 27, 2012
Related Publication 20210338540A1 · Nov 4, 2021
References Cited (5)
US 5505949A · Benitez · 1996 [cited by examiner]
US 6455058B1 · Sun · 2002 [cited by examiner]
US 20060239953A1 · Clapp · 2006 [cited by examiner]
US 20090214628A1 · de Rijk · 2009 [cited by examiner]
US 20120014885A1 · Collier · 2012 [cited by examiner]